Eli Lilly Lebanon Lands One of Seven FDA PreCheck Slots Nationwide

The FDA received more than 80 applications for its new PreCheck pilot and awarded seven slots. Eli Lilly's active pharmaceutical ingredient plant under construction in Lebanon, Boone County, is one of them. Lilly committed $4.5 billion to two Lebanon sites in May 2026; total committed investment at the LEAP Innovation District now exceeds $18 billion. PreCheck moves FDA technical engagement and pre-submission meetings before construction is complete, the 73-plus rejected applicants carry the full uncertainty premium of legacy inspection scheduling.

For Indiana construction contractors, pharma engineering firms, and utility providers already under contract on that campus: FDA pre-submission timelines compress the tail risk of a delayed approval stretching your payment schedules. That's a talking point for your existing lender conversations now, not at project close.